Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.75 -0.23 (-2.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings (ASBP) Return on Assets [ROA] (2025 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) recorded Return on Assets [ROA] of -147.15% in Q2 2026, up 1125.74 percentage points from -1272.89% a year earlier and up 230.40 percentage points from the prior quarter.

Analysis

Aspire Biopharma Holdings (ASBP) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Aspire Biopharma Holdings reported Return on Assets [ROA] of -3353.18%, down 3340.17 percentage points from FY2024.

  • Across earlier years, Return on Assets [ROA] came in at -13.01% in FY2024 (-12.79 pp) and -0.22% in FY2023.
  • Per Business Quant, the preceding three quarters came in at -377.55% (Q1 2026), -1541.25% (Q4 2025) and -1250.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.08%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.65%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 2.45%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 10.60%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 9.10%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 9.29%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -6.13%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.14%
10 Aspire-Lakewood Holdings 65.71 Mn 44.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -147.15%
Mar 31, 2026 -377.55%
Dec 31, 2025 -1,541.25%
Sep 30, 2025 -1,250.73%
Jun 30, 2025 -1,272.89%
API Access

Aspire Biopharma Holdings Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ASBP&period=max&api_key=YOUR_API_KEY